January 25, 2012
- Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.
- Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years.
- Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes.
- A novel strategy for long-term implantable artificial pancreas.
